Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jung, E.
Right arrow Articles by Bollag, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, E.
Right arrow Articles by Bollag, W. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 4, 569-576, April 1999
© 1999 Oxford University Press

Sustained phospholipase D activation is associated with keratinocyte differentiation

EunMi Jung, Soraya Betancourt-Calle, RaShawn Mann-Blakeney, Richard D. Griner and Wendy Bollinger Bollag1

Program in Cell Signaling, Institute of Molecular Medicine and Genetics, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912-2630, USA

Our previous results and data in the literature have suggested a potential role for phospholipase D (PLD) in the regulation of epidermal keratinocyte growth and differentiation. Therefore, we investigated the effect of agents reported to modulate keratinocyte growth and differentiation on PLD activation. The purported protein kinase C (PKC) `inhibitor', staurosporine (Stsp), has been reported to activate PKC in keratinocytes, eliciting many of the same effects as active tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA). Stsp also induces a programmed pattern of differentiation similar to that seen in keratinocytes in vivo; TPA, on the other hand, appears to preferentially elicit markers consistent with late (granular) differentiation. In contrast, bradykinin is reported to stimulate keratinocyte proliferation. We found that these three agents had different effects on PLD activation in primary mouse epidermal keratinocytes. TPA increased PLD activity acutely and in a sustained fashion. In contrast, Stsp did not acutely activate PLD and inhibited acute TPA-induced activation of PLD. However, treatment of keratinocytes with Stsp for longer time periods (3–5 h) induced sustained PLD activation and this long-term effect was additive with that of TPA. Bradykinin activated PLD acutely but transiently. Both TPA and Stsp increased transglutaminase activity, a marker of late differentiation, whereas bradykinin had little or no effect on either cell proliferation or transglutaminase activity. These results suggest that a sustained activation of PLD is associated with the induction of keratinocyte differentiation. We hypothesize that PLD activity mediates late keratinocyte differentiation through generation of diacylglycerol and activation of specific PKC isoforms. Furthermore, we propose that the profound and immediate TPA-induced stimulation of PLD activity `drives' the keratinocytes to late differentiation steps. However, the less efficacious (and more gradual) sustained activation of PLD by Stsp may allow a patterned differentiation more like that observed in skin.

Abbreviations: BSA, bovine serum albumin; DAG, sn-1,2-diacylglycerol; FBS, fetal bovine serum; IC50, half-maximal inhibitory concentration; ITS, insulin transferrin and selenious acid; ITS+, ITS + linoleic acid/BSA; MEM, minimum essential medium; PA, phosphatidic acid; PEt, phosphatidylethanol; PLD, phospholipase D; PKC, protein kinase C; SDS, sodium dodecyl sulfate; SFKM, serum-free keratinocyte medium; Stsp, staurosporine; TCA, trichloroacetic acid; TPA, 12-O-tetradecanoylphorbol-13-acetate.

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
S. Krisanaprakornkit, P. Chotjumlong, P. Kongtawelert, and V. Reutrakul
Involvement of phospholipase D in regulating expression of anti-microbial peptide human -defensin-2
Int. Immunol., January 1, 2008; 20(1): 21 - 29.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. B. Bollag, P. Kent, S. White, M. Malinova, C. M. Isales, and R. A. Calle
Characterization and Phospholipase D Mediation of the Angiotensin II Priming Response in Adrenal Glomerulosa Cells
Endocrinology, February 1, 2007; 148(2): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. B. Bollag, X. Zhong, M. E. Dodd, D. M. Hardy, X. Zheng, and W. T. Allred
Phospholipase D Signaling and Extracellular Signal-Regulated Kinase-1 and -2 Phosphorylation (Activation) Are Required for Maximal Phorbol Ester-Induced Transglutaminase Activity, a Marker of Keratinocyte Differentiation
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Komati, F. Naro, S. Mebarek, V. De Arcangelis, S. Adamo, M. Lagarde, A.-F. Prigent, and G. Nemoz
Phospholipase D Is Involved in Myogenic Differentiation through Remodeling of Actin Cytoskeleton
Mol. Biol. Cell, March 1, 2005; 16(3): 1232 - 1244.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. A. Shapiro, S. Ray, E. Jung, W. T. Allred, and W. B. Bollag
Putative Conventional Protein Kinase C Inhibitor Godecke 6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Stimulates Transglutaminase Activity in Primary Mouse Epidermal Keratinocytes
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 352 - 358.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.